AI-generated summary
The authors compared 595-nm pulsed dye laser alone with 5-aminolevulinic acid applied topically before the same laser in 181 patients with superficial hemangioma over 24 months. They report complete clearing in 67.4% of the combined-treatment group versus 37.0% of the laser-alone group, with similar adverse effects in both groups.
- Participants
- 181
- Who or what was studied
- Patients with superficial hemangioma (infants and children; age range not stated in the abstract)
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The abstract does not describe blinding or control of confounding, and the unequal group sizes (119 versus 46) and loss of 16 patients before final follow-up limit the strength of the comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.